Table of Contents

2019-2024 Global Psoriatic Arthritis Therapeutics Drug Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis Therapeutics Drug Consumption 2014-2024
2.1.2 Psoriatic Arthritis Therapeutics Drug Consumption CAGR by Region
2.2 Psoriatic Arthritis Therapeutics Drug Segment by Type
2.2.1 NF Inhibitors
2.2.2 Interleukin Inhibitors
2.2.3 PDE4 Inhibitors
2.2.4 Others
2.3 Psoriatic Arthritis Therapeutics Drug Consumption by Type
2.3.1 Global Psoriatic Arthritis Therapeutics Drug Consumption Market Share by Type (2014-2019)
2.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Type (2014-2019)
2.3.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Type (2014-2019)
2.4 Psoriatic Arthritis Therapeutics Drug Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Psoriatic Arthritis Therapeutics Drug Consumption by Application
2.5.1 Global Psoriatic Arthritis Therapeutics Drug Consumption Market Share by Application (2014-2019)
2.5.2 Global Psoriatic Arthritis Therapeutics Drug Value and Market Share by Application (2014-2019)
2.5.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Application (2014-2019)

3 Global Psoriatic Arthritis Therapeutics Drug by Players
3.1 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Players
3.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Players (2017-2019)
3.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Players (2017-2019)
3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Players
3.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Players (2017-2019)
3.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Players (2017-2019)
3.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Players
3.4 Global Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Psoriatic Arthritis Therapeutics Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Psoriatic Arthritis Therapeutics Drug by Regions
4.1 Psoriatic Arthritis Therapeutics Drug by Regions
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Consumption by Regions
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Value by Regions
4.2 Americas Psoriatic Arthritis Therapeutics Drug Consumption Growth
4.3 APAC Psoriatic Arthritis Therapeutics Drug Consumption Growth
4.4 Europe Psoriatic Arthritis Therapeutics Drug Consumption Growth
4.5 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Consumption Growth

5 Americas
5.1 Americas Psoriatic Arthritis Therapeutics Drug Consumption by Countries
5.1.1 Americas Psoriatic Arthritis Therapeutics Drug Consumption by Countries (2014-2019)
5.1.2 Americas Psoriatic Arthritis Therapeutics Drug Value by Countries (2014-2019)
5.2 Americas Psoriatic Arthritis Therapeutics Drug Consumption by Type
5.3 Americas Psoriatic Arthritis Therapeutics Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Psoriatic Arthritis Therapeutics Drug Consumption by Countries
6.1.1 APAC Psoriatic Arthritis Therapeutics Drug Consumption by Countries (2014-2019)
6.1.2 APAC Psoriatic Arthritis Therapeutics Drug Value by Countries (2014-2019)
6.2 APAC Psoriatic Arthritis Therapeutics Drug Consumption by Type
6.3 APAC Psoriatic Arthritis Therapeutics Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Psoriatic Arthritis Therapeutics Drug by Countries
7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Consumption by Countries (2014-2019)
7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Value by Countries (2014-2019)
7.2 Europe Psoriatic Arthritis Therapeutics Drug Consumption by Type
7.3 Europe Psoriatic Arthritis Therapeutics Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug by Countries
8.1.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Value by Countries (2014-2019)
8.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Consumption by Type
8.3 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Psoriatic Arthritis Therapeutics Drug Distributors
10.3 Psoriatic Arthritis Therapeutics Drug Customer

11 Global Psoriatic Arthritis Therapeutics Drug Market Forecast
11.1 Global Psoriatic Arthritis Therapeutics Drug Consumption Forecast (2019-2024)
11.2 Global Psoriatic Arthritis Therapeutics Drug Forecast by Regions
11.2.1 Global Psoriatic Arthritis Therapeutics Drug Forecast by Regions (2019-2024)
11.2.2 Global Psoriatic Arthritis Therapeutics Drug Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Psoriatic Arthritis Therapeutics Drug Forecast by Type
11.8 Global Psoriatic Arthritis Therapeutics Drug Forecast by Application

12 Key Players Analysis
12.1 AbbVie
12.1.1 Company Details
12.1.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 AbbVie News
12.2 Janssen Biotech
12.2.1 Company Details
12.2.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Janssen Biotech News
12.3 Novartis
12.3.1 Company Details
12.3.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Novartis News
12.4 Amgen
12.4.1 Company Details
12.4.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Amgen News
12.5 CELGENE CORPORATION
12.5.1 Company Details
12.5.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 CELGENE CORPORATION News
12.6 Pfizer
12.6.1 Company Details
12.6.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Pfizer News
12.7 Eli Lilly
12.7.1 Company Details
12.7.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Eli Lilly News
12.8 UCB
12.8.1 Company Details
12.8.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 UCB News
12.9 Biogen
12.9.1 Company Details
12.9.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Biogen News
12.10 Bristol-Myers Squibb
12.10.1 Company Details
12.10.2 Psoriatic Arthritis Therapeutics Drug Product Offered
12.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Bristol-Myers Squibb News

13 Research Findings and Conclusion